$2,540.44 consulting Payment -- Teva Pharmaceuticals to Dr. Amanda Lewis

Internal Medicine Physician Receives $2,540 Consulting Fee from Teva Pharmaceuticals

This page provides a detailed analysis of a $2,540.44 consulting payment from Teva Pharmaceuticals to Dr. Amanda Lewis. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$2,540.44
Payment Typeconsulting
Payment NatureConsulting Fee
Pharmaceutical CompanyTeva Pharmaceuticals
PhysicianDr. Amanda Lewis
NPI Number1556976258
Physician SpecialtyInternal Medicine
LocationCity, AL
Date of Payment2024-10-22
Conflict AssessmentLow -- Routine

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Teva Pharmaceuticals made a $2.5K consulting payment to Amanda Lewis, a Internal Medicine specialist in City, AL. Amanda Lewis received a $2,540.44 consulting fee from Teva Pharmaceuticals on October 22, 2024. The payment was for consulting services related to Internal Medicine. This record is part of the CMS Open Payments program, designed for transparency in healthcare.

Patient Guidance: What This Payment Means for You

This payment represents a fee for professional consulting services provided by a physician to a pharmaceutical company. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Consulting fees are common in Internal Medicine, but the specific amount and nature should be reviewed against industry benchmarks for similar services.

Regulatory Context: Sunshine Act Requirements

This transaction is reported under the Physician Payments Sunshine Act, requiring disclosure of payments made by manufacturers of drugs, devices, and biologics to physicians and teaching hospitals.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding consulting Payments

Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.

Frequently Asked Questions About This Payment

What was this $2.5K payment for?

This was a consulting payment of $2.5K from Teva Pharmaceuticals to Amanda Lewis, categorized as "Consulting Fee". The payment was reported under the Sunshine Act (CMS Open Payments).

Does Amanda Lewis accept pharmaceutical money?

Yes, Amanda Lewis received this $2.5K payment from Teva Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Amanda Lewis's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this consulting payment?

A consulting payment of $2.5K may reflect legitimate advisory services the physician provides. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Internal Medicine?

To compare this payment against Internal Medicine averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Internal Medicine physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Amanda Lewis's relationship with Teva Pharmaceuticals?

The payment amount is specific and documented. This $2.5K consulting payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Internal Medicine?

The payment type is 'consulting', indicating a professional service engagement.

What should patients do after learning about this payment?

This payment represents a fee for professional consulting services provided by a physician to a pharmaceutical company.

What else should I know about this consulting payment?

The date of payment falls within the current reporting period.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.